BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3280 related articles for article (PubMed ID: 33169684)

  • 1. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Kowalski K; Mulak A
    J Neurogastroenterol Motil; 2019 Jan; 25(1):48-60. PubMed ID: 30646475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
    Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
    Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease.
    Köhler CA; Maes M; Slyepchenko A; Berk M; Solmi M; Lanctôt KL; Carvalho AF
    Curr Pharm Des; 2016; 22(40):6152-6166. PubMed ID: 27604604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease.
    Go J; Chang DH; Ryu YK; Park HY; Lee IB; Noh JR; Hwang DY; Kim BC; Kim KS; Lee CH
    Nutr Res; 2021 Feb; 86():96-108. PubMed ID: 33551257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and gut microbiota.
    Hu X; Wang T; Jin F
    Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-derived β-amyloid: Likely a centerpiece of the gut-brain axis contributing to Alzheimer's pathogenesis.
    Jin J; Xu Z; Zhang L; Zhang C; Zhao X; Mao Y; Zhang H; Liang X; Wu J; Yang Y; Zhang J
    Gut Microbes; 2023; 15(1):2167172. PubMed ID: 36683147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
    Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate.
    Sun J; Xu J; Yang B; Chen K; Kong Y; Fang N; Gong T; Wang F; Ling Z; Liu J
    Mol Nutr Food Res; 2020 Jan; 64(2):e1900636. PubMed ID: 31835282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
    Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
    J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 164.